IRWD
IRONWOOD PHARMACEUTICALS INC
Nasdaq Pharmaceutical Preparations Accelerated filer
Smaller reporting company

Key Financials

Operating Income
$98.5M
↑ 5.8%
Net Income
$24.0M
↑ 1155.2%
Revenue
$296.2M
↑ 520.7%
EPS (Diluted)
$0.15
↑ 1600.0%
Cash & Equivalents
$215.5M
↑ 143.3%
Shareholders' Equity
$-261835000.00
↑ 13.1%
Total Assets
$396.9M
↑ 13.1%
Operating Cash Flow
$127.0M
↑ 22.7%

Recent SEC Filings

Form Type Filed Date Link
SCHEDULE 13G/A 5/15/2026 View on SEC
SCHEDULE 13G/A 5/14/2026 View on SEC
8-K 5/13/2026 View on SEC
10-Q 5/7/2026 View on SEC
8-K 5/7/2026 View on SEC
ARS 4/28/2026 View on SEC
DEFA14A 4/28/2026 View on SEC
DEF 14A 4/28/2026 View on SEC
SCHEDULE 13G/A 4/27/2026 View on SEC
SCHEDULE 13G/A 3/27/2026 View on SEC

Company Information

Field Value
Ticker IRWD
Company Name IRONWOOD PHARMACEUTICALS INC
CIK 1446847
Sector Pharmaceutical Preparations
Industry Accelerated filer
Smaller reporting company
Exchange Nasdaq
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 617-621-7722